Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-17 4:00 pm Purchase | 2026-06-10 | 13G | SHATTUCK LABS INC STTK | Deep Track Capital LP | 5,000,033 5.170% | 5,000,033 (New Position) | Filing History |
| 2026-05-29 4:37 pm Purchase | 2026-05-22 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Deep Track Capital LP | 3,055,027 5.810% | 3,055,027 (New Position) | Filing History |
| 2026-05-15 09:14 am Sale | 2026-03-31 | 13G | DEFINIUM THERAPEUTICS INC DFTX | Deep Track Capital LP | 3,000,000 3.010% | -2,676,540 (-47.15%) | Filing History |
| 2026-05-15 08:46 am Purchase | 2026-03-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Deep Track Capital LP | 3,600,000 8.460% | 600,000 (+20.00%) | Filing History |
| 2026-05-15 08:46 am Purchase | 2026-03-31 | 13G | OCULAR THERAPEUTIX INC OCUL | Deep Track Capital LP | 20,850,000 9.530% | 9,615,868 (+85.60%) | Filing History |
| 2026-05-15 08:45 am Purchase | 2026-03-31 | 13G | NURIX THERAPEUTICS INC NRIX | Deep Track Capital LP | 6,345,244 6.170% | 845,244 (+15.37%) | Filing History |
| 2026-05-15 08:42 am Sale | 2026-03-31 | 13G | INVENTIVA SA ADR IVA | Deep Track Capital LP | 7,800,465 3.760% | -3,868,518 (-33.15%) | Filing History |
| 2026-05-15 08:40 am Sale | 2026-03-31 | 13G | GERON CORP GERN | Deep Track Capital LP | 31,720,278 4.950% | -790,993 (-2.43%) | Filing History |
| 2026-05-15 08:39 am Purchase | 2026-03-31 | 13G | CORMEDIX INC CRMD | Deep Track Capital LP | 6,274,076 7.940% | 1,318,589 (+26.61%) | Filing History |
| 2026-05-15 08:38 am Purchase | 2026-03-31 | 13G | BICARA THERAPEUTICS INC BCAX | Deep Track Capital LP | 4,062,500 6.210% | 1,312,500 (+47.73%) | Filing History |
| 2026-05-15 08:37 am Sale | 2026-03-31 | 13G | APELLIS PHARMACEUTICALS INC CO APLS | Deep Track Capital LP | 4,532,374 3.550% | -2,467,626 (-35.25%) | Filing History |
| 2026-05-12 4:28 pm Purchase | 2026-05-05 | 13G | PERSONALIS INC PSNL | Deep Track Capital LP | 5,760,627 5.510% | 5,760,627 (New Position) | Filing History |
| 2026-05-08 4:18 pm Purchase | 2026-05-01 | 13G | HEMAB THERAPEUTICS HLDGS INC C COAG | Deep Track Capital LP | 3,600,996 8.150% | 3,600,996 (New Position) | Filing History |
| 2026-05-08 4:17 pm Purchase | 2026-05-01 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Deep Track Capital LP | 5,417,660 5.300% | 2,892,827 (+114.57%) | Filing History |
| 2026-04-30 4:00 pm Purchase | 2026-04-23 | 13G | ALTIMMUNE INC ALT | Deep Track Capital LP | 19,417,221 9.990% | 19,417,221 (New Position) | Filing History |
| 2026-04-07 4:27 pm Purchase | 2026-03-30 | 13G | ALUMIS INC ALMS | Deep Track Capital LP | 7,362,035 5.980% | 7,362,035 (New Position) | Filing History |
| 2026-03-17 4:16 pm Purchase | 2026-03-09 | 13G | ACLARIS THERAPEUTICS INC ACRS | Deep Track Capital LP | 9,345,000 7.000% | 9,345,000 (New Position) | Filing History |
| 2026-03-11 4:05 pm Purchase | 2026-03-04 | 13G | VERA THERAPEUTICS INC VERA | Deep Track Capital LP | 3,921,362 5.500% | 3,921,362 (New Position) | Filing History |
| 2026-03-04 4:15 pm Purchase | 2026-02-17 | 13G | IMMUNIC INC IMUX | Deep Track Capital LP | 1,145,400 8.690% | 1,145,400 (New Position) | Filing History |
| 2026-02-13 08:53 am Sale | 2025-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Deep Track Capital LP | 2,524,833 2.650% | -2,854,164 (-53.06%) | Filing History |